Spike Proteins, Not Diamonds May be Forever By Brian Simpson
Early in the Covid plandemic, the health authorities proclaimed that the mRNA Covid vax stayed in the injection site and did not migrate to organs in the body. This was refuted by biodistribution studies requested by the Japanese government, that showed that the mRNA spike proteins did in fact travel to organs such as the heart, brain and ovaries. The Australian health authorities were pretty quiet on this issue. Still, since the early biodistribution studies, other research has found that not only do the spike proteins travel all over the body, but they remain in the body for a considerable length of time.
One recent study, published in the journal Proteomics Clinical Applications, found that the spike proteins were still in the bodies of test subjects almost six months after injection. But six months was the time the study was concluded, and does not indicate that the spike proteins ceased to exist at the time. It could well continue indefinitely, since it is unclear what mechanism could stop the spike protein synthesis once it gets rolling. It is no wonder that people are dying suddenly after multiple jabs. And the culture of jabbing continues.
“When the mRNA COVID-19 vaccines were rolled out, the science was adamant that the resultant spike proteins would remain near the injection site and then quickly be removed from the body. And even after a couple years of evidence showing that neither key hypothesis came true, the science has not budged much. A new study published August 31 in Proteomics Clinical Applications is adding to the body of knowledge revealing that the mRNA vaccines are problematic and that their artificial spike proteins in fact travel all over the body and remain in one’s system for long periods of time. This latest evidence comes by way of the study “Detection of recombinant Spike protein in the blood of individuals vaccinated against SARS-CoV-2: Possible molecular mechanisms,” represented by corresponding authors Carlo Brogna, M.D., DDS, Craniomed Group Facility Srl, and Marina Piscopo, Ph.D. professor, Department of Biology at the University of Naples Federico II.”
The SARS-CoV-2 pandemic prompted the development and use of next-generation vaccines. Among these, mRNA-based vaccines consist of injectable solutions of mRNA encoding for a recombinant Spike, which is distinguishable from the wild-type protein due to specific amino acid variations introduced to maintain the protein in a prefused state. This work presents a proteomic approach to reveal the presence of recombinant Spike protein in vaccinated subjects regardless of antibody titer.
Mass spectrometry examination of biological samples was used to detect the presence of specific fragments of recombinant Spike protein in subjects who received mRNA-based vaccines.
The specific PP-Spike fragment was found in 50% of the biological samples analyzed, and its presence was independent of the SARS-CoV-2 IgG antibody titer. The minimum and maximum time at which PP-Spike was detected after vaccination was 69 and 187 days, respectively.
Conclusions and clinical relevance
The presented method allows to evaluate the half-life of the Spike protein molecule “PP” and to consider the risks or benefits in continuing to administer additional booster doses of the SARS-CoV-2 mRNA vaccine. This approach is of valuable support to complement antibody level monitoring and represents the first proteomic detection of recombinant Spike in vaccinated subjects.”
“Remember how we were told that “the vaccine stays in the arm” and that “harmless spike protein is only produced for a couple of days.” They said they were sure of that, despite no data to confirm their statements.
Well, sadly, it turns out that they lied to us. The data is now in, and it proves such claims wrong!
A clever scientific study by Brogna et al., just published, detected the presence of spike protein in COVID-vaccinated people six MONTHS after vaccination - and excluded the possibility of cross-contamination of experimental data with wild-circulating COVID infections.
What the Scientists Did
The study's authors used a sensitive test, called mass-spectrometry to detect a specific amino-acid sequence that exists only in the vaccine-induced spike protein.
To remind my readers, mRNA COVID vaccines contain genetic code to produce the so-called “spike protein,” a component of the SARS-CoV-2 virus that allows the virus to penetrate and infect human cells. During the penetration process, called “fusion,” the viral spike protein changes shape, becoming a spear of sorts, penetrating the cell surface.
The only modification that both Pfizer and Moderna did was to “prefusion stabilize” the vaccine-encoded spike protein to prevent it from changing its shape and be more stable in the human body.
The scientists decided to look for that specific, genetically modified protein component.
Experimental design: Mass spectrometry examination of biological samples was used to detect the presence of specific fragments of recombinant Spike protein in subjects who received mRNA-basedvaccines.
The replacement, using two proline amino acids, is referred to as “PP” by the study authors (PP stands for proline-proline). They are Italian and possibly did not realize that “PP” sounds naughty, so in most English literature, the sequence is called “2P”. Leaving kindergarten humor aside, the study authors zero in on the spike protein component that only exists in the COVID vaccine and does NOT occur in the naturally existing Sars-Cov-2 virus.
To be sure that their finding is not spurious, scientists included a control group of people who never received the COVID vaccines:
The study group, from southern Italy, was 40 subjects, 20 were vaccinated with the full cycle of mRNA vaccine as of April 2022, being part of the health sector, and 20 were unvaccinated with negativity for COVID-19 to nasopharyngeal test and with no titer of any antibodies. Other 20 unvaccinated persons were added that were positive for COVID-19.
The three groups were looked at.
It turns out that only the people in the vaccinated subgroup were found to carry vaccine-derived spike protein. What is worse, vaccine spike protein was found as late as six months after the last dose!
The specific PP-Spike fragment was found in 50% of the biological sample analyzed (Figures 1C–E and 2). This presence was independent of the SARS-CoV-2 IgG antibody titer. The antibody titers had a geometric mean of 629.86BAU/mL (Figure 1E). The minimum time PP-Spike was detected was 69 days after vaccination, while the maximum time was 187days. Allcontrols (samples from unvaccinated individuals) were negative. The control group (20 unvaccinated people) was also tested after contracting COVID-19 and was negative for PP-spike.
Nowhere does the study state that spike protein production ends after 187 days - the upper limit on time after vaccination was an artefact of the study design.”